Research output: Contribution to journal › Article › peer-review
Nuclear magnetic resonance spectroscopy as a tool for thequantitative analysis of water and ions in pharmaceuticals: Exampleof heparin. / Монахова, Юлия Борисовна; Diehl, Bernd.
In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 154, 30.05.2018, p. 332-338.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Nuclear magnetic resonance spectroscopy as a tool for thequantitative analysis of water and ions in pharmaceuticals: Exampleof heparin
AU - Монахова, Юлия Борисовна
AU - Diehl, Bernd
N1 - Funding Information: We warmly thank K. Seitz and T. Lüke for their excellent technical assistance. We thank Professor Fareed and Dr. Yao for providing samples of ovine origin. Y. Monakhova acknowledges support of the Russian Ministry of Science and Education (project 4.1063.2017/4.6). Appendix A
PY - 2018/5/30
Y1 - 2018/5/30
N2 - Heparin is a linear, highly sulfated glycosaminoglycan (GAG), which consists of repeating disaccharide units of β-D-glucuronic acid or α-L-iduronic acid and α-D-glucosamine. While robust analytical approaches exist for the characterization of organic composition of heparin preparations, there is a lack of methods for the simultaneous quantification of inorganic compounds (water, anions, cations) in this matrix. A nuclear magnetic resonance (NMR) spectrometric method for heparin characterization described in US Pharmacopeia was extended to simultaneous analysis of the inorganic ions (sodium, calcium, and chloride), acetate as well as water content. NMR control of these parameters is possible with only one sample preparation according to the US Pharmacopeia using just four sequential NMR experiments ( 1H, 2D, 23Na, and 35Cl) with a total measurement time less than 20 min. Validation results in terms of precision, reproducibility, limit of detection and recovery demonstrated that the developed method is fit-for-purpose for the authentic heparin samples. The quantitative data for a representative set of more than hundred Na- and Ca- heparin and low-molecular weight heparin (LMWH) samples were discussed regarding animal origin and the type of anticoagulant. NMR spectrometry represents a unique analytical method suitable for the simultaneous quantitative control of organic and inorganic composition of heparin.
AB - Heparin is a linear, highly sulfated glycosaminoglycan (GAG), which consists of repeating disaccharide units of β-D-glucuronic acid or α-L-iduronic acid and α-D-glucosamine. While robust analytical approaches exist for the characterization of organic composition of heparin preparations, there is a lack of methods for the simultaneous quantification of inorganic compounds (water, anions, cations) in this matrix. A nuclear magnetic resonance (NMR) spectrometric method for heparin characterization described in US Pharmacopeia was extended to simultaneous analysis of the inorganic ions (sodium, calcium, and chloride), acetate as well as water content. NMR control of these parameters is possible with only one sample preparation according to the US Pharmacopeia using just four sequential NMR experiments ( 1H, 2D, 23Na, and 35Cl) with a total measurement time less than 20 min. Validation results in terms of precision, reproducibility, limit of detection and recovery demonstrated that the developed method is fit-for-purpose for the authentic heparin samples. The quantitative data for a representative set of more than hundred Na- and Ca- heparin and low-molecular weight heparin (LMWH) samples were discussed regarding animal origin and the type of anticoagulant. NMR spectrometry represents a unique analytical method suitable for the simultaneous quantitative control of organic and inorganic composition of heparin.
KW - Heparin
KW - Inorganic ions
KW - NMR spectroscopy
KW - Water content
UR - http://www.scopus.com/inward/record.url?scp=85044101836&partnerID=8YFLogxK
U2 - 10.1016/j.jpba.2018.03.028
DO - 10.1016/j.jpba.2018.03.028
M3 - Article
VL - 154
SP - 332
EP - 338
JO - Journal of Pharmaceutical and Biomedical Analysis
JF - Journal of Pharmaceutical and Biomedical Analysis
SN - 0731-7085
ER -
ID: 35397813